OBJECTIVE: To investigate the prevalence and prognostic factors of joint surgery in a large cohort of patients with rheumatoid arthritis, whose treatment, clinical and radiographic data have been assessed at predefined points in time since disease onset. METHODS: Data on surgical interventions were retrospectively obtained from 482 patients with rheumatoid arthritis whose follow-up data for at least 2 years were available, including treatment and response to treatment during the first 2 years. Survival time until the first surgical intervention and until the first major surgical intervention was determined for the total study population by Kaplan-Meier survival curves. Three separate Cox regression analyses were carried out to determine which variables measured at baseline, during the first year and during the first 2 years were predictors for joint surgery. RESULTS: 27% of the patients underwent surgical interventions. Mean survival time until the first surgical intervention was 10.4 years. The percentage of patients with a surgical intervention was 10% lower in the group with response to treatment when compared with the non-response group. Next to a delayed start with disease-modifying antirheumatic drugs, fast radiographic progression during the first year and first 2 years was a predictor of joint surgery in the multivariate regression analyses. CONCLUSION: Treatment with disease-modifying antirheumatic drugs immediately after diagnosis results in less joint surgery when compared with a delayed start. Furthermore, joint surgery is carried out more often in patients who do not respond to treatment.
RCT Entities:
OBJECTIVE: To investigate the prevalence and prognostic factors of joint surgery in a large cohort of patients with rheumatoid arthritis, whose treatment, clinical and radiographic data have been assessed at predefined points in time since disease onset. METHODS: Data on surgical interventions were retrospectively obtained from 482 patients with rheumatoid arthritis whose follow-up data for at least 2 years were available, including treatment and response to treatment during the first 2 years. Survival time until the first surgical intervention and until the first major surgical intervention was determined for the total study population by Kaplan-Meier survival curves. Three separate Cox regression analyses were carried out to determine which variables measured at baseline, during the first year and during the first 2 years were predictors for joint surgery. RESULTS: 27% of the patients underwent surgical interventions. Mean survival time until the first surgical intervention was 10.4 years. The percentage of patients with a surgical intervention was 10% lower in the group with response to treatment when compared with the non-response group. Next to a delayed start with disease-modifying antirheumatic drugs, fast radiographic progression during the first year and first 2 years was a predictor of joint surgery in the multivariate regression analyses. CONCLUSION: Treatment with disease-modifying antirheumatic drugs immediately after diagnosis results in less joint surgery when compared with a delayed start. Furthermore, joint surgery is carried out more often in patients who do not respond to treatment.
Authors: Amalia A van Everdingen; Johannes W G Jacobs; Dirk R Siewertsz Van Reesema; Johannes W J Bijlsma Journal: Ann Intern Med Date: 2002-01-01 Impact factor: 25.391
Authors: Suzan M M Verstappen; Johannes W G Jacobs; Johannes W J Bijlsma; Anton H M Heurkens; Christina van Booma-Frankfort; Evert Jan ter Borg; Dick M Hofman; Maaike J van der Veen Journal: Arthritis Rheum Date: 2003-07
Authors: Mark C Genovese; Joan M Bathon; Richard W Martin; Roy M Fleischmann; John R Tesser; Michael H Schiff; Edward C Keystone; Mary Chester Wasko; Larry W Moreland; Arthur L Weaver; Joseph Markenson; Grant W Cannon; George Spencer-Green; Barbara K Finck Journal: Arthritis Rheum Date: 2002-06
Authors: Michael E Weinblatt; Edward C Keystone; Daniel E Furst; Larry W Moreland; Michael H Weisman; Charles A Birbara; Leah A Teoh; Steven A Fischkoff; Elliot K Chartash Journal: Arthritis Rheum Date: 2003-01
Authors: Jetske Viveen; Michel P J van den Bekerom; Job N Doornberg; Alesha Hatton; Richard Page; Koen L M Koenraadt; Christopher Wilson; Gregory I Bain; Ruurd L Jaarsma; Denise Eygendaal Journal: Acta Orthop Date: 2019-08-27 Impact factor: 3.717
Authors: Cristiano S Moura; Michal Abrahamowicz; Marie-Eve Beauchamp; Diane Lacaille; Yishu Wang; Gilles Boire; Paul R Fortin; Louis Bessette; Claire Bombardier; Jessica Widdifield; John G Hanly; Debbie Feldman; Walter Maksymowych; Christine Peschken; Cheryl Barnabe; Steve Edworthy; Sasha Bernatsky Journal: Arthritis Res Ther Date: 2015-08-03 Impact factor: 5.156
Authors: Elena Nikiphorou; Sam Norton; Adam Young; Lewis Carpenter; Josh Dixey; David Andrew Walsh; Patrick Kiely Journal: Ann Rheum Dis Date: 2016-03-15 Impact factor: 19.103
Authors: James M Gwinnutt; Deborah P M Symmons; Alexander J MacGregor; Jacqueline R Chipping; Chloe Lapraik; Tarnya Marshall; Mark Lunt; Suzanne M M Verstappen Journal: Rheumatology (Oxford) Date: 2017-09-01 Impact factor: 7.580
Authors: Irazú Contreras-Yáñez; G Guaracha-Basáñez; E Díaz-Borjón; M Iglesias; V Pascual-Ramos Journal: BMC Musculoskelet Disord Date: 2018-10-20 Impact factor: 2.362